0
0
28 words
0
Comments
FDA approves Roctavian, the first gene therapy for treatment of adults with severe hemophilia A.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-adults-severe-hemophilia
Create an account or login to join the discussion